Sirtex stuns market with $1.6bn US takeover offer
SYDNEY: Cancer drug developer Sirtex last night surprised investors with an agreed 1.58 billion takeover
SYDNEY: Cancer drug developer Sirtex last night surprised investors with an agreed 1.58 billion takeover